⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 16, 2024

Supplementary Data from Ncoa2 promotes CD8+ T cell-mediated anti-tumor immunity by stimulating T-cell activation via upregulation of PGC-1α critical for mitochondrial function

Xiancai Zhong Hongmin Wu Ching Ouyang Wencan Zhang Yun Shi Yi-Chang Wang David K. Ann Yousang Gwack Weirong Shang Zuoming Sun

View at Publisher

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

All supplementray figures and tables

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zhong et al. (2024) studied this question.

synapsesocial.com/papers/68e586c1b6db643587523428 https://doi.org/10.1158/2326-6066.27026837.v1

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Data from Ncoa2 promotes CD8+ T cell-mediated anti-tumor immunity by stimulating T-cell activation via upregulation of PGC-1α critical for mitochondrial function2024
2Supplementary Data from Tumor cell–intrinsic c-Myb upregulation stimulates antitumor immunity in a murine colorectal cancer model2024
3Supplementary Data from Tumor cell–intrinsic c-Myb upregulation stimulates antitumor immunity in a murine colorectal cancer model2024
4Supplementary Data from IL18 Receptor Signaling Regulates Tumor-Reactive CD8<sup>+</sup> T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in a Pancreatic Cancer Model2025
5Supplementary Data1 from One CD4<sup>+</sup>TCR and One CD8<sup>+</sup>TCR Targeting Autochthonous Neoantigens Are Essential and Sufficient for Tumor Eradication2024

Supplementary Data1 from One CD4<sup>+</sup>TCR and One CD8<sup>+</sup>TCR Targeting Autochthonous Neoantigens Are Essential and Sufficient for Tumor Eradication2024
Supplementary Data from PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING-Type I Interferon Signaling in Glioblastoma2024
Supplementary Data from PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING-Type I Interferon Signaling in Glioblastoma2024